| IRVIX | RMEBX | IRVIX / RMEBX | |
| Total Expense Ratio | 0.43 | 1.07 | 40% |
| Annual Report Gross Expense Ratio | 0.65 | 1.07 | 61% |
| Fund Existence | 17 years | 11 years | - |
| Gain YTD | 5.648 | 2.231 | 253% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 302M | 112B | 0% |
| Annual Yield % from dividends | 6.74 | 1.08 | 622% |
| Returns for 1 year | -4.83 | 7.30 | -66% |
| Returns for 3 years | 19.85 | 28.21 | 70% |
| Returns for 5 years | 41.05 | 43.15 | 95% |
| Returns for 10 years | 116.11 | 103.95 | 112% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FCGBX | 3.08 | 0.03 | +0.98% |
| Templeton Global Dynamic Income C | |||
| RGLEX | 28.94 | -0.26 | -0.89% |
| American Funds Global Insight R-4 | |||
| RUSTX | 16.84 | -0.18 | -1.06% |
| Russell Inv US Strategic Equity M | |||
| ISFIX | 18.48 | -0.23 | -1.23% |
| VY® Columbia Contrarian Core I | |||
| PGRCX | 46.20 | -0.78 | -1.66% |
| BNY Mellon Worldwide Growth C | |||